Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective
Knowing the costs associated with the pathologies that generate loss of vision and irreversible legal blindness is essential to understand the socioeconomic impact associated with these pathologies. Furthermore, the high cost of treating these diseases makes necessary to coordinate efforts between administrations, together with the support of patient associations, to meet their needs.
Authors
- Jacinto Zulueta
- Alfredo García‐Layana (ORCID: https://orcid.org/0000-0001-5732-2797)
- Miguel Ángel Casado (ORCID: https://orcid.org/0000-0002-8743-6653)
- Laura Salinas-Ortega (ORCID: https://orcid.org/0000-0002-7066-0659)
- Gonzaga Garay‐Aramburu (ORCID: https://orcid.org/0000-0001-5255-8426)
- Araceli Casado Gómez (ORCID: https://orcid.org/0000-0003-0201-7247)
- Luis de Pablo
- José M. Ruiz‐Moreno (ORCID: https://orcid.org/0000-0001-9636-0788)
- J Clavero Salvador
- Inmaculada Fernández
- Álvaro Muñoz (ORCID: https://orcid.org/0000-0003-0896-1423)
- Anxo Fernandez
- Inmaculada Bañón-Rodriguez
- Xenia Acebes
- Delfina Balonga
Institutions
- Andalusian Health Service (ES)
- Hospital de Basurto (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Hospital Universitario Miguel Servet (ES)
- Clinica Universidad de Navarra (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
- AbbVie (Spain) (ES)
- Servicio Gallego de Salud (ES)
- Pharmacoeconomics and Health Outcomes Research Iberia (Spain) (ES)
- Barcelona Macula Foundation (ES)
Publication Details
- Journal
- Health Economics Review
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1186/s13561-024-00546-y
- Citations
- 10
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 5.39